reported a trend toward a greater rate of tumor regression (36.7% for KRAS WT versus 11% for KRAS mutant), however it did not reach statistical significance ( P = .12) [ 101 ].
1
0.1200
0.1200
reported a trend toward a greater rate of tumor regression (36.7% for KRAS WT versus 11% for KRAS mutant), however it did not reach statistical significance ( P = .12) [ 101 ].